Skip to main content
. 2018 Oct 1;18:938. doi: 10.1186/s12885-018-4832-5

Fig. 1.

Fig. 1

Tumor CD8+ and FOXP3+ expression as assessed with IHC in breast cancer. a CD8 IHC stain in breast carcinoma highlights abundant CD8+ T lymphocytes (200X magnification); (b) FOXP3 IHC stain in breast carcinoma highlights FOXP3+ lymphocytes (200X magnification). FOXP3+ forkhead box protein 3, IHC immunohistochemistry